HomeISCNF • OTCMKTS
add
Isracann Biosciences Inc
Previous close
$0.00010
Day range
$0.00 - $0.00
Market cap
2.61M CAD
Avg Volume
2.59K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Aug 2022info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 288.35K | — |
Net income | -316.00K | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -277.92K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Aug 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 198.05K | — |
Total assets | 4.04M | — |
Total liabilities | 3.91M | — |
Total equity | 124.87K | — |
Shares outstanding | 175.99M | — |
Price to book | ∞ | — |
Return on assets | -17.73% | — |
Return on capital | -347.21% | — |
Cash Flow
Net change in cash
| (CAD) | Aug 2022info | Y/Y change |
|---|---|---|
Net income | -316.00K | — |
Cash from operations | -163.40K | — |
Cash from investing | — | — |
Cash from financing | 151.55K | — |
Net change in cash | -15.88K | — |
Free cash flow | -27.07K | — |
About
Founded
2010
Headquarters
Website
